根据合并方案,预计Redx股东将持有该集团约63%的股份,而Jounce股东将持有剩余约37%的股份。
就业务合并而言,预计将向原始Jounce股东分配一项...查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:33
$Jounce Therapeutics(JNCE)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001640455-23-000100 Act: 33 Size: 46 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:36
$Jounce Therapeutics(JNCE)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001640455-23-000105 Act: 33 Size: 46 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:48
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000107 Size: 24 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:51
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000114 Size: 10 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:51
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000111 Size: 20 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:12
$Jounce Therapeutics(JNCE)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001640455-23-000084 Act: 34 Size: 34 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-06 04:36
$Jounce Therapeutics(JNCE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001214659-23-006565 Act: 34 Size: 95 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-06 04:42
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027688 Size: 12 KB 网页链接查看全文
Jounce Therapeutics(JNCE)2023-05-04 19:48
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000106 Size: 16 KB 网页链接查看全文
智通财经APP获悉,英国生物技术公司Redx Pharma plc和美国Jounce Therapeutics Inc(JNCE.US)将合并,成立一家4.25亿美元的实体,专门治疗癌症和纤维化疾病。截至发稿,Jounce盘前涨30.25%,报1.29美元。 两家公司周四表示,Redx股东将以... 网页链接
$Jounce Therapeutics(JNCE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-027685 Size: 7 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027688 Size: 12 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027692 Size: 6 KB 网页链接
$Jounce Therapeutics(JNCE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001214659-23-006565 Act: 34 Size: 95 KB 网页链接
$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001276 Act: 33 Size: 1 KB 网页链接
$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001275 Act: 33 Size: 1 KB 网页链接
$Jounce Therapeutics(JNCE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000336 Act: 34 Size: 2 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000111 Size: 20 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000112 Size: 26 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000113 Size: 8 KB 网页链接